1. Home
  2. BBAR vs MTSR Comparison

BBAR vs MTSR Comparison

Compare BBAR & MTSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBAR
  • MTSR
  • Stock Information
  • Founded
  • BBAR 1886
  • MTSR 2022
  • Country
  • BBAR Argentina
  • MTSR United States
  • Employees
  • BBAR N/A
  • MTSR N/A
  • Industry
  • BBAR Commercial Banks
  • MTSR
  • Sector
  • BBAR Finance
  • MTSR
  • Exchange
  • BBAR Nasdaq
  • MTSR NYSE
  • Market Cap
  • BBAR 3.4B
  • MTSR 3.0B
  • IPO Year
  • BBAR N/A
  • MTSR 2025
  • Fundamental
  • Price
  • BBAR $16.37
  • MTSR $28.98
  • Analyst Decision
  • BBAR Buy
  • MTSR Strong Buy
  • Analyst Count
  • BBAR 1
  • MTSR 6
  • Target Price
  • BBAR $27.00
  • MTSR $55.25
  • AVG Volume (30 Days)
  • BBAR 656.0K
  • MTSR 1.1M
  • Earning Date
  • BBAR 08-20-2025
  • MTSR 08-26-2025
  • Dividend Yield
  • BBAR 6.07%
  • MTSR N/A
  • EPS Growth
  • BBAR 9.91
  • MTSR N/A
  • EPS
  • BBAR 0.57
  • MTSR N/A
  • Revenue
  • BBAR $2,595,064,489.00
  • MTSR N/A
  • Revenue This Year
  • BBAR N/A
  • MTSR N/A
  • Revenue Next Year
  • BBAR $35.30
  • MTSR N/A
  • P/E Ratio
  • BBAR $9.38
  • MTSR N/A
  • Revenue Growth
  • BBAR N/A
  • MTSR N/A
  • 52 Week Low
  • BBAR $7.05
  • MTSR $12.30
  • 52 Week High
  • BBAR $25.01
  • MTSR $37.99
  • Technical
  • Relative Strength Index (RSI)
  • BBAR 37.59
  • MTSR N/A
  • Support Level
  • BBAR $15.90
  • MTSR N/A
  • Resistance Level
  • BBAR $17.10
  • MTSR N/A
  • Average True Range (ATR)
  • BBAR 0.70
  • MTSR 0.00
  • MACD
  • BBAR -0.00
  • MTSR 0.00
  • Stochastic Oscillator
  • BBAR 17.19
  • MTSR 0.00

About BBAR Banco BBVA Argentina S.A. ADS

Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.

About MTSR METSERA INC

Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.

Share on Social Networks: